Literature DB >> 29434176

Associations Between CagA, VacA, and the Clinical Outcomes of Helicobacter Pylori Infections in Okinawa, Japan.

Tomoko Inagaki1, Shin Nishiumi1, Yoshiyuki Ito2, Akiyo Yamakawa3, Yukinao Yamazaki3, Masaru Yoshida1,4, Takeshi Azuma1.   

Abstract

Helicobacter pylori, which is involved in the pathogenesis of gastroduodenal disease, produces CagA and VacA as major virulence factors. CagA is classified into East Asian and Western types based on the number and sequences of its Glu-Pro-Ile-Tyr-Ala motifs. The vacA gene has three polymorphic regions: the signal (s), intermediate (i), and middle (m) regions. The lowest gastric cancer mortality rate is seen in Okinawa. On the Japanese mainland (Honshu), most H. pylori produce s1/m1-VacA, which exhibits strong toxicity, and East Asian-type CagA. However, the H. pylori detected in Okinawa produces s1/m2-VacA, which exhibits weak toxicity, or s2/m2-VacA, which is non-toxic, and Western-type CagA. Studies about the i-region of vacA have been performed around the world, but there have been few such studies in Japan. Therefore, the aim of this study was to assess the relationships between the clinical outcomes of H. pylori infections in Okinawa, vacA (especially the i-region genotype), and cagA. H. pylori strains that were collected from patients with gastric cancer or gastric ulcers in Okinawa only produced the i1-type VacA virulence factor. The vacuolating cytotoxin activity of i1-type VacA was stronger than that of i2-type VacA, suggesting that the i-region genotype of vacA is closely associated with vacuolating cytotoxin activity. These results indicate that the i-region genotype of vacA is a useful marker of both H. pylori virulence and the clinical outcomes of H. pylori infections in Okinawa, Japan.

Entities:  

Keywords:  Helicobacter pylori; CagA; Okinawa; VacA

Mesh:

Substances:

Year:  2017        PMID: 29434176      PMCID: PMC5826021     

Source DB:  PubMed          Journal:  Kobe J Med Sci        ISSN: 0023-2513


  33 in total

1.  Analysis of Helicobacter pylori vacA gene and serum antibodies to VacA in Japan.

Authors:  D Shirasaka; N Aoyama; K Satonaka; K Shirakawa; H Yoshida; T Sakai; T Ikemura; Y Shinoda; M Sakashita; M Miyamoto; K Yahiro; A Wada; H Kurazono; T Hirayama; M Kasuga
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta.

Authors:  K Yahiro; T Niidome; M Kimura; T Hatakeyama; H Aoyagi; H Kurazono; K i Imagawa; A Wada; J Moss; T Hirayama
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

3.  vacA i-region subtyping.

Authors:  Hiroaki Ogiwara; David Y Graham; Yoshio Yamaoka
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

4.  The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity.

Authors:  C Pagliaccia; M de Bernard; P Lupetti; X Ji; D Burroni; T L Cover; E Papini; R Rappuoli; J L Telford; J M Reyrat
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

5.  Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells.

Authors:  J A Garner; T L Cover
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

6.  Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries.

Authors:  Y Yamaoka; T Kodama; O Gutierrez; J G Kim; K Kashima; D Y Graham
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

7.  Association between diversity in the Src homology 2 domain--containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer.

Authors:  Takeshi Azuma; Shiho Yamazaki; Akiyo Yamakawa; Masahiro Ohtani; Atsushi Muramatsu; Hiroyuki Suto; Yoshiyuki Ito; Manabu Dojo; Yukinao Yamazaki; Masaru Kuriyama; Yoshihide Keida; Hideaki Higashi; Masanori Hatakeyama
Journal:  J Infect Dis       Date:  2004-02-02       Impact factor: 5.226

8.  Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains.

Authors:  T L Cover; M K Tummuru; P Cao; S A Thompson; M J Blaser
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

9.  Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads.

Authors:  Ratha-Korn Vilaichone; Varocha Mahachai; Somying Tumwasorn; Jeng-Yih Wu; David Y Graham; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2004-10       Impact factor: 5.753

10.  Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.

Authors:  J L Telford; P Ghiara; M Dell'Orco; M Comanducci; D Burroni; M Bugnoli; M F Tecce; S Censini; A Covacci; Z Xiang
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  2 in total

1.  Epitope peptides of Helicobacter pylori CagA antibodies from sera by whole-peptide mapping.

Authors:  Shamshul Ansari; Junko Akada; Yuichi Matsuo; Seiji Shiota; Yoko Kudo; Tadayoshi Okimoto; Kazunari Murakami; Yoshio Yamaoka
Journal:  J Gastroenterol       Date:  2019-05-02       Impact factor: 7.527

Review 2.  Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment.

Authors:  Jacek Baj; Alicja Forma; Monika Sitarz; Piero Portincasa; Gabriella Garruti; Danuta Krasowska; Ryszard Maciejewski
Journal:  Cells       Date:  2020-12-25       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.